iRIS serves oncology trials at Beth Israel Deaconess Medical CenterBoston Children's HospitalBrigham and Women's HospitalDana-Farber Cancer InstituteMassachusetts General Hospital, and other affiliated institutions. 

Visit the iRIS Wiki for more details.
ANNOUNCEMENT
Dear DF/HCC Research Community,
 
We will be holding an iRIS Office Hours session on Thursday, April 29th at 11am. The topics for this session are:

  • Changes in the upcoming iRIS release
  • Submission of consent forms for initial submissions
  • Obtaining projected IRB dates

Please feel free to submit questions relating to these or other iRIS topics in advance using the link below.
Note: Pre-registration is not required. Please use the attachment to save this session to your calendar.
Oncology trials in Boston are a collaborative effort involving many from many institutions. The transition to this new system, iRIS, represents an opportunity to streamline all of the processes involved, and move trials from submission to activation, and to our patients, more quickly. Please take advantage of all of the provided information and resources to help us make this transition as seamless as possible.

Sincerely,
Jeffrey Meyerhardt, MD, MPH
Associate Director for Clinical Trials,
Dana-Farber/Harvard Cancer Center
Drew Memmott
Associate Director for Administration,
Dana-Farber/Harvard Cancer Center
Erica Woulf
Senior Director for Research Informatics Operations,
Dana-Farber/Harvard Cancer Center